5791.0000 -72.50 (-1.24%)
NSE Jan 14, 2026 10:36 AM
Volume: 12,282
 

5791.00
-1.24%
ICICI Securities Limited
Alkem Laboratories’ (Alkem) Q1FY23 performance was lower than our estimates on the profitability front. Revenue declined 5.7% YoY to Rs 25.8bn (I-Sec: Rs 24.9bn) on a high base due to covid.
Alkem Laboratories Ltd. is trading above all available SMAs
More from Alkem Laboratories Ltd.
Recommended